Dr Irmgard Irminger-Finger – Chief Scientific Officer/Executive Director PD, PhD (appointed 16 June 2016)
Melbourne, Australia, 15 January 2021: BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) announces that Dr Irmgard Irminger-Finger has stepped down from the board. Dr IrmingerFinger, who resides in Geneva, Switzerland
sure... they were going to get the lung test to be a success in the next 5 months after 5 years of failure and changing their focus to other technology, including a merger with new tech, which caused the share price to go nuts
Ann: Commencement of Legal Proceedings Against BARD1, page-46
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.025(4.27%) |
Mkt cap ! $61.75M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 60.0¢ | 56.0¢ | $46.60K | 81.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11847 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 9849 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |